ClinicalTrials.gov
public full text
Public Domain
Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
The purpose of this study is to better understand the cardiovascular effects of the vasodilatory peptide Angiotensin (1-7) in human hypertension. In this study, the investigators will test the hypothesis that systemic Angiotensin (1-7) infusion produces negligible effects with intact baroreceptors, and that the cardiovascular effects of this peptide are unmasked following elimination of baroreflex buffering.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Review on pathophysiology, clinical manifestations, and diagnosis of hypertension and associated cardiovascular diseases#270473
- Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure#857146
- Damage and Renal Clearance of Glycocalyx in Cardiac Surgery#806992
- Study of Renin-angiotensin System in Mechanically Ventilated Subjects#897408
- Attenuated Relationships Between Indexes of Volume Overload and Atrial Natriuretic Peptide in Uncontrolled, Sustained Volume-Dependent Primary Hypertension#466875
Record · ID 896236
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive